RNAZ - Transcode Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Transcode Therapeutics's activity chart (see below) currently has 4 price targets and 16 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 16-Apr-2025. First documented stock forecast 07-Jun-2022.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Jun-2022

$7840

$7837.82 (359533.03%)

Show more analysts

What is RNAZ (Transcode Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on RNAZ (Transcode Therapeutics) with a proven track record?

EMILY BODNAR

Which analyst has the most public recommendations on RNAZ (Transcode Therapeutics)?

Emily Bodnar works at HC WAINWRIGHT and has 17 price targets and 20 ratings on RNAZ

Which analyst is the currently most bullish on RNAZ (Transcode Therapeutics)?

Emily Bodnar with highest potential upside - $7837.82

Which analyst is the currently most reserved on RNAZ (Transcode Therapeutics)?

Emily Bodnar with lowest potential downside - $7835.03